Stephens analyst Jacob Johnson reiterated an Equal Weight rating and $5.00 price target on Lifecore Biomedical (NASDAQ: LFCR).The analyst comments ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Lifecore Biomedical (LFCR) PT Raised to $6 at StephensOctober 7, 2024 9:19 AM Form 10-Q LIFECORE BIOMEDICAL, For: Aug 25October 4, 2024 7:42 AM Form 8-K LIFECORE BIOMEDICAL, For: Oct 03October 4, 2024 7:36 AM Lifecore Biomedical (LFCR) Reports Q1 Loss of $0.53/shOctober 4, 2024 7:33 AM Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate UpdateOctober 4, 2024 7:31 AM Lifecore Biomedical (LFCR) Prices 5.93M Share Offering at $4.10/shOctober 4, 2024 7:21 AM Lifecore Biomedical Raises $24.3 Million in Private Placement of Common StockOctober 4, 2024 7:20 AM Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024October 3, 2024 4:05 PM